Incyte Corporation (Nasdaq:INCY) will ring the opening bell at the
NASDAQ MarketSite today to support the start of Blood Cancer Awareness
Month and the launch of Voices of MPN™, a new community awareness
initiative to unite, connect and support people living with
myeloproliferative neoplasms (MPNs), a group of rare and progressive
blood cancers that includes myelofibrosis, polycythemia vera and
essential thrombocythemia.1 September 12 has been designated
the inaugural MPN Awareness Day.
Incyte President and Chief Executive Officer Paul A. Friedman, M.D. will
perform the honorary bell ringing ceremony today from 9:15 to 9:30 a.m.
ET. A live webcast will be available at http://www.nasdaq.com/about/marketsitetowervideo.asx.
Dr. Friedman will be joined by members of the Incyte leadership team and
the patient advocacy community.
“Incyte is committed to making a difference in the lives of patients
with cancer,” stated Dr. Friedman. “We ring the NASDAQ opening bell
today alongside the MPN community to mark the start of blood cancer
awareness month and bring attention to rare blood cancers, like MPNs. We
are simultaneously launching a new initiative that is intended to
increase awareness of MPNs and encourage members of the community to
join together and raise their voices in support.”
Voices of MPN invites all members of the MPN community, including
patients, advocacy organizations, and health care professionals to
engage in a variety of events designed to help raise the voices of
individuals affected by MPNs. The Voices
of MPN website links people to disease information, educational
programs and community activities, while inviting them to share their
stories. A Wall of Voices (a virtual wall of recognition) invites a
person to submit pictures and a few lines of testimony about an
individual or organization who has touched the lives of those impacted
by MPNs. Voices of MPN Facebook, YouTube and Pinterest pages invite
people to learn more about MPNs and help spread awareness through social
media sharing.
In conjunction with the initiative, Incyte is calling for nominations
for “MPN Heroes: Recognizing the Champions Among Us,” a program to
recognize individuals and organizations who have provided health care
above and beyond the standard of care, demonstrated outstanding
commitment, provided leadership to the community, or advanced science
for MPNs. To learn more about MPN Heroes, visit www.MPNHeroes.com.
To learn more about Voices of MPN, visit www.VoicesofMPN.com.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary small molecule drugs for oncology and inflammation. For
additional information on Incyte, please visit the Company's website at www.incyte.com.
References
1 “Learning About MPNs,” MPN Research Foundation, http://www.mpnresearchfoundation.org/Overview-Page
Copyright Business Wire 2013